Provided by Tiger Fintech (Singapore) Pte. Ltd.

DexCom

61.80
-6.3400-9.30%
Pre-market: 61.36-0.4400-0.71%04:20 EDT
Volume:5.40M
Turnover:336.75M
Market Cap:24.15B
PE:43.40
High:65.01
Open:64.89
Low:61.48
Close:68.14
Loading ...

DexCom (DXCM) Q4 Earnings Preview: What's in the Cards?

Zacks
·
06 Feb

Should You Buy DexCom Stock Before Feb. 13?

Motley Fool
·
06 Feb

DexCom Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
06 Feb

Here’s Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM)

Insider Monkey
·
04 Feb

DexCom Shares Rise Following Upgrade From Redburn Atlantic

MT Newswires Live
·
04 Feb

Redburn Atlantic Upgrades DexCom to Buy From Neutral, Adjusts Price Target to $115 From $85

MT Newswires Live
·
03 Feb

DexCom upgraded to Buy from Neutral at Redburn Atlantic

TIPRANKS
·
03 Feb

LIVE MARKETS-Stock splits could be on the rebound

Reuters
·
01 Feb

DexCom Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
31 Jan

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 P.m. Eastern Time.

THOMSON REUTERS
·
30 Jan

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.

Business Wire
·
30 Jan

DexCom Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
28 Jan

Should We Be Delighted With DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 34%?

Simply Wall St.
·
25 Jan

DexCom Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
25 Jan

Abbott banks on glucose monitors, new launches to ride out China, currency hit

Reuters
·
22 Jan

ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains?

Zacks
·
22 Jan

DexCom Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
22 Jan

DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?

Zacks
·
21 Jan

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025

Simply Wall St.
·
21 Jan

Barclays Adjusts DexCom Price Target to $92 From $113, Maintains Equal Weight Rating

MT Newswires Live
·
21 Jan